SCHEMBL19080019

SCHEMBL19080019

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5cc6c(cc5c4)oc4cc5ccccc5cc46)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.41
ESR2 Q92731 7/20 0.41
GPR84 Q9NQS5 2/20 0.39
ALOX5 P09917 1/20 0.36
GSTP1 P09211 1/20 0.36
MIF P14174 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
CYP1A2 P05177 2/20 0.34
PGR P06401 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC8 Q9BY41 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20053302 0.95 ESR1 (0.38) ESR1ESR2GPR84ALOX5GSTP1
SCHEMBL22062816 0.95 AHR (0.39) ESR1ESR2GPR84ALOX5KDM4E
SCHEMBL19076403 0.93 AHR (0.38) ESR1ESR2GPR84ALOX5KDM4E
SCHEMBL19080082 0.93 GSTP1 (0.40) ESR1ESR2GPR84ALOX5GSTP1
SCHEMBL19076413 0.92 MAOA (0.37) ESR1ESR2GPR84ALOX5KDM4E
SCHEMBL17931950 0.92 ESR1 (0.41) ESR1ESR2GPR84ALOX5KDM4E
SCHEMBL17931956 0.92 ESR1 (0.41) ESR1ESR2GPR84ALOX5KDM4E
SCHEMBL19080022 0.91 ABCG2 (0.41) ESR1ESR2GPR84KDM4EALDH1A1
SCHEMBL19081601 0.90 ESR1 (0.40) ESR1ESR2GPR84ALOX5KDM4E
SCHEMBL22062787 0.90 ESR1 (0.40) ESR1ESR2GPR84ALOX5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ESR1 153/4885ESR2 510/4885GPR84 2425/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ESR1 153/4885ESR2 510/4885GPR84 2425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.